Literature DB >> 22341572

Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.

Jenny L Wiley1, Valerie J Smith, Jianhong Chen, Billy R Martin, John W Huffman.   

Abstract

To develop SAR at both the cannabinoid CB(1) and CB(2) receptors for 3-(1-naphthoyl)indoles bearing moderately electron withdrawing substituents at C-4 of the naphthoyl moiety, 1-propyl and 1-pentyl-3-(4-fluoro, chloro, bromo and iodo-1-naphthoyl) derivatives were prepared. To study the steric and electronic effects of substituents at the 8-position of the naphthoyl group, the 3-(4-chloro, bromo and iodo-1-naphthoyl)indoles were also synthesized. The affinities of both groups of compounds for the CB(1) and CB(2) receptors were determined and several of them were evaluated in vivo in the mouse. The effects of these substituents on receptor affinities and in vivo activity are discussed and structure-activity relationships are presented. Although many of these compounds are selective for the CB(2) receptor, only three JWH-423, 1-propyl-3-(4-iodo-1-naphthoyl)indole, JWH-422, 2-methyl-1-propyl-3-(4-iodo-1-naphthoyl)indole, the 2-methyl analog of JWH-423 and JWH-417, 1-pentyl-3-(8-iodo-1-naphthoyl)indole, possess the desirable combination of low CB(1) affinity and good CB(2) affinity. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341572      PMCID: PMC3298571          DOI: 10.1016/j.bmc.2012.01.038

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  33 in total

1.  8-Chloro- and 5,8-Dichloro1-naphthoic Acids.

Authors:  Jianhong Chen; Valerie J Smith; John W Huffman
Journal:  Org Prep Proced Int       Date:  2010       Impact factor: 1.628

2.  Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists.

Authors:  B R Martin; R Jefferson; R Winckler; J L Wiley; J W Huffman; P J Crocker; B Saha; R K Razdan
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

3.  Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.

Authors:  Jenny L Wiley; Christopher S Breivogel; Anu Mahadevan; Roger G Pertwee; Maria Grazia Cascio; Daniele Bolognini; John W Huffman; D Matthew Walentiny; Robert E Vann; Raj K Razdan; Billy R Martin
Journal:  Eur J Pharmacol       Date:  2010-11-27       Impact factor: 4.432

4.  A general method for acylation of indoles at the 3-position with acyl chlorides in the presence of dialkylaluminum chloride.

Authors:  T Okauchi; M Itonaga; T Minami; T Owa; K Kitoh; H Yoshino
Journal:  Org Lett       Date:  2000-05-18       Impact factor: 6.005

5.  Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Authors:  P J Little; D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

6.  Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.

Authors:  John W Huffman; Gulay Zengin; Ming-Jung Wu; Jianzhong Lu; George Hynd; Kristen Bushell; Alicia L S Thompson; Simon Bushell; Cindy Tartal; Dow P Hurst; Patricia H Reggio; Dana E Selley; Michael P Cassidy; Jenny L Wiley; Billy R Martin
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

7.  Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity.

Authors:  Jenny L Wiley; Reneé G Jefferson; Graeme Griffin; John Liddle; Shu Yu; John W Huffman; Billy R Martin
Journal:  Pharmacology       Date:  2002-10       Impact factor: 2.547

8.  Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Authors:  D R Compton; K C Rice; B R De Costa; R K Razdan; L S Melvin; M R Johnson; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

9.  Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.

Authors:  B R Martin; D R Compton; S F Semus; S Lin; G Marciniak; J Grzybowska; A Charalambous; A Makriyannis
Journal:  Pharmacol Biochem Behav       Date:  1993-10       Impact factor: 3.533

10.  Cannabinoid receptor localization in brain.

Authors:  M Herkenham; A B Lynn; M D Little; M R Johnson; L S Melvin; B R de Costa; K C Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

View more
  3 in total

1.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

Review 2.  Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.

Authors:  Jenny L Wiley; Julie A Marusich; John W Huffman
Journal:  Life Sci       Date:  2013-09-23       Impact factor: 5.037

3.  Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.

Authors:  Giuseppe Floresta; Orapan Apirakkan; Antonio Rescifina; Vincenzo Abbate
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.